Haranaka, Miwa
25  results:
Search for persons X
?
2

P2X3 Receptor Antagonist Eliapixant in Phase I Clinical Tri..:

Li, Xuening ; Haranaka, Miwa ; Li, Hui...
Clinical Pharmacokinetics.  63 (2024)  6 - p. 901-915 , 2024
 
?
 
?
6

Phase 1 Study to Investigate the Safety, Tolerability, and ..:

Noda, Naoto ; Hamatani, Tatsuto ; Shibue, Yuta...
Clinical Pharmacology in Drug Development.  11 (2022)  10 - p. 1136-1146 , 2022
 
?
10

A phase I study of high dose camostat mesylate in healthy a..:

Kitagawa, Junsaku ; Arai, Hayato ; Iida, Hiroyuki...
Clinical and Translational Science.  14 (2021)  5 - p. 1967-1976 , 2021
 
?
11

Levocetirizine Oral Disintegrating Tablet: A Randomized Ope..:

Ino, Hiroko ; Shiramoto, Masanari ; Eto, Takashi...
Clinical Pharmacology in Drug Development.  9 (2020)  7 - p. 805-812 , 2020
 
?
12

Bioequivalence of a Newly Developed Dabigatran Etexilate Ta..:

Harada, Akiko ; Ikushima, Ippei ; Haranaka, Miwa..
American Journal of Cardiovascular Drugs.  20 (2019)  3 - p. 249-258 , 2019
 
?
 
?
15

Intraperitoneal administration attenuates thiazolidinedione..:

Oribe, Junya ; Kakuma, Tetsuya ; Haranaka, Miwa...
Obesity Research & Clinical Practice.  6 (2012)  3 - p. e249-e261 , 2012
 
1-15